Pentixapharm

Pentixapharm

Pentixapharm

Pentixapharm develop PentixaFor and PentixaTher as a theranostic radiopharmaceutical pair.
Raised
$16.7M
Latest funding
€15,000,000
Venture capital (Series A) - 2020
Eckert Life Science Accelerator
Team Size
1–10
Employees
Location
Headquarters
€15,000,000 Venture capital (Series A)
FinSMEs

Pentixapharm Secures €15M in Series A Funding